It is now well established that pituitary dwarfism may be recessively inherited (Hanhart, 1925; Nowakowski and Lenz, 1961; Trygstad and Seip, 1964; Rimoin, Merimee, and McKusick, 1966) . The condition has repeatedly been observed in sibs (Biben and Gordan, 1955; Scharer and Prader, 1960;  Nowakowski and Lenz, 1961; Trygstad and Seip, 1964; Bierich, 1964; Brasel, Wright, Wilkins, and Blizzard, 1965; Rimoin et al., 1966) , and sometimes as the result of consanguineous marriages (Hanhart, 1925; Rimoin et al., 1966;  this report), or in cousins (Trygstad and Seip, 1964) . Probably the 28 cases of inherited dwarfism reported by Hanhart in 1925 from Oberegg and Samnauntal in Switzerland, and from the island of Veglia in Yugoslavia, were of pituitary origin, though diagnostic criteria were less well established at that time.
It has been commonly believed that pituitary dwarfs do not mature sexually, or at least do so very poorly, due to lack of pituitary gonadotropic hormones in addition to the somatotropin deficiency. But this is not always the case (Hewer, 1944; Antonin, 1961; Bierich, 1964; Brasel et al., 1965; Rimoin et al., 1966) .
At least four different forms of inherited pituitary dwarfism seem to have been established. (a) In the most common, all or several anterior pituitary hormones are deficient, though often to a variable degree. These dwarfs do not mature sexually.
(b) Steiner and Boggs (1965) have described congenital absence of the pituitary gland with hypothyroidism, hypoadrenalism, and hypogonadism in two sibs, brother and sister, offspring of first-cousin parents.
(c) Laron, Pertzelan, and Mannheimer (1966) have reported an interesting sibship with evidence of a functional deficiency of growth hormone, though radioimmunoassay gave high values of Received April 27, 1967. serum growth hormone. An abnormal, biologically inactive growth hormone in high concentration is a reasonable assumption in these patients since they responded well to exogenous growth hormone.
(d) The fourth group includes dwarfs with documented, isolated growth hormone deficiency with low plasma growth hormone levels by radioimmunoassay (Rimoin et al., 1966; this report Greulich and Pyle (1959) . The metyrapone test was performed by the oral administration of 70-80 mg./kg. divided in 6 doses in 24 hours, the daily excretion of 17-OHCS and 17-KS being measured one day before, during, and the day after. Insulin sensitivity was studied by means of a combined insulin-glucose tolerance test (Trygstad, 1965) . Plasma growth hormone was determined radioimmunologically by Dr. Nils Norman, Aker Hospital, Oslo, Norway, before and one hour after i.v.
insulin injection (0-1 I.U./kg.). The tests were performed in the morning in the fasting state.
The material for linkage calculation is given in the Appendix (Table I) Case Reports Case 1. IV. 4 (see Fig. 1 ) was born on September 9, 1930, following normal pregnancy and delivery. His rate of growth was slow from the first year of life, though his intellectual development has been normal. Puberty was delayed, starting at 17, but was completed spontaneously. The external genitals are of normal adult size (Fig. 2) . Pubic hair, body hair, and beard are well developed. He has normal libido, and has had several sexual contacts with the opposite sex, but has not married.
He continued to grow until he was over 20, and has reached an ultimate height of 142 cm. Epiphysial fusion is now complete. In adult life moderate obesity has developed, his weight being 64 kg. His short stature has led to emotional problems, and he has been under treatment for abuse of alcohol. He is employed by the local telephone company.
The most important laboratory findings are given in the Appendix (Table II) .
Case 2. IV. 9 was born on December 9, 1945, following normal pregnancy and delivery. Her birthweight was 3000 g. Growth retardation was apparent in infancy and became very marked. She also has bilateral dislocation of hip joints. Her intelligence and school progress have been normal.
At the age of 8 years and 10 months she was 88 -5 cm., and at 15 years she was 101 *5 cm., her weight being 14 7 kg.
She was admitted to our department in September When restudied at the age of 21 she still measured 109 cm., and the epiphysial lines were fused. She had regular, normal menses. Breast development was normal. Pubic hair was still sparse and axillary hair lacking (Fig. 2) . Laboratory data are given in the Appendix (Table II) .
Case 3. IV. 11 was born March 30, 1950, following normal pregnancy and delivery. His birthweight was normal. Psychomotor development was normal, but growth was retarded from the first years of life.
He was admitted to our department aged 14j. His height was 115 cm. (height age 5 years and 2 months), weight 18 8 kg. Body proportions were normal, with no signs of sexual development. Skeletal age was 9 years. Pneumoencephalogram was normal. Chromosome analysis was normal. There was a normal response following metyrapone administration.
Treatment with human growth hormone, 2 mg. three times a week, was begun at the age of 14 years and 7 months, after which he grew 13 cm. in 24 months, and there was a comparable advance of skeletal age.
When restudied in November 1966, at age 16k, he showed some growth of the external genitals, signifying incipient puberty (Fig. 2 ), though no pubic or axillary hair was present. The height was 128 cm. Laboratory data are given in the Appendix (Table II) .
Discussion
The pedigree of the reported family is shown in Fig. 1 All 3 patients were normally developed at birth and showed marked growth retardation from infancy. Body proportions are normal (Fig. 2) . The oldest had shown complete sexual maturation, starting at 17. He continued to grow until he was more than 20, and had reached an ultimate height of 142 cm. His younger sister, who in addition has bilateral hip dislocation, has also gone through spontaneous puberty, with menarche at 18 years and 4 months; she has normal breast development, but pubic hair is sparse, and axillary hair lacking. Her final height is 109 cm. The youngest patient is now 17; his bone age is 1 1 years, and he is in incipient puberty.
The urinary output of pituitary gonadotropin is within normal limits in all 3: high normal in the oldest, low normal in the 2 youngest. The excretion of androgens is normal in Case 1. In his severely dwarfed sister, now 21 years of age, the excretion of dehydro-epiandrosterone, etiocholanolone, oestriol, and oestradiol is within normal limits, while androsterone and oestrone excretion is somewhat low. The younger brother is just in the beginning of his pubertal development, and the output of gonadal hormones is naturally still low. Rimoin et al. (1966) . They studied in detail 6 cases, belonging to 2 kindreds, with clinical pictures very similar to our patients. 4 of the 6 have produced children, proving that these subjects are fertile; lactation had also been normal. Puberty had been delayed by 2 to 10 years in each. Bierich (1964) (Rimoin et al., 1966; this report) . (2) Pituitary dwarfism with high serum GH in radioimmunoassay, presumably biologically inactive (Laron et al., 1966) . (3) Hypogonadotropic pituitary dwarfism (Hanhart, 1925; Trygstad and Seip, 1964;  and others). (4) Aplasia of the pituitary gland (Steiner and Boggs, 1965) .
Familial, hereditary hypogonadotropic hypogonadism without dwarfism or other signs of pituitary failure except gonadotropin deficiency have been described by Le Marquand (1954) , Biben and Gordan (1955), and Lynch, Ozer, McNutt, Johnson, and Jampolsky (1960) . Diabetes insipidus may also be genetically determined in some families. Isolated deficiences of thyrotropin (Shuman, 1953) and of ACTH (Steinberg, Shecter, and Segal, 1954; Odell, Green, and Williams, 1960; Cleveland, Green, and Migeon, 1960) Plasma growth hormone levels were low, and there was no increase following insulin-induced hypoglycaemia.
The youngest patient has been treated with human growth hormone for 2 years with good result.
Of the genetic marker systems segregating in the family, calculations of linkage to this disease were indicative of free recombination concerning the ABO and MNS systems, and gave a very slight suggestion of linkage in the Rh, Inv, Gc, and Lp systems (see Appendix).
We wish to thank Dr. M. K. Fagerhol, Mrs. S. K. Gundersen, Miss M. Homberg, Dr. E. Monn, and Dr. T. Reinskou, for performing blood-, serum-, and enzyme-typing, Dr. A. G. Steinberg, Cleveland, for Inv typing, and Dr. T. Gedde-Dahl for valuable assistance with the linkage calculations. Shuman, C. R. (1953 The a priori probability of linkage has been raised to an a posteriori probability of 5-3% for relation to the Rh system, 8 2% for the Inv system, 5 -3°% for the Gc system, and to 7 1% for the Lp system.
The Fisher-Finney values for the Inv relation (Table  IV) are explained by the fact that this method takes into account the four Inv homozygotes only (IV., 5, 6, 7, and 8) . None of these four was dwarfed. Given linkage to the Inv system, an absolute linkage can be excluded, since the linkage phases of the parents are opposite.
The evidence of nanism-Rh linkage is slightly enhanced by the distribution of the c d e gene complex in the family. Given linkage to Rh, a closer linkage than 6% can be excluded at the 5% level of significance.
The amount of information is small in all relations (see Table IV ), and it must be concluded that the genetic marker systems in this family show no convincing indication of linkage. 
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